Schedule
Print6:30am to 7:45am | Registration and Breakfast | |
7:45am to 8:00am | Seating | |
8:00am to 8:15am |
Welcome, Introductions, Course Objectives
Samuel Z. Goldhaber, MD, Peter Libby, MD, and Patrick T. O'Gara, MD |
8:15am to 8:45am |
Inflammation: At the Nexus of Atherosclerosis, Aging, and Cancer
Peter Libby, MD |
|
8:45am to 8:55am | Discussion, Q&A | |
8:55am to 9:25am |
CANTOS: Effect of Interleukin-1β Inhibition with Canakinumab on Atherosclerosis and Lung Cancer
Paul M Ridker, MD, MPH |
|
9:25am to 9:35am | Discussion, Q&A | |
9:35am to 10:05am |
Reducing Triglyceride Levels to Reduce Adverse Cardiovascular Outcomes
Aruna D. Pradhan, MD, MPH |
|
10:05am to 10:15am | Discussion, Q&A | |
10:15am to 10:35am |
Coffee break
Refreshments provided |
|
10:35am to 11:05am |
Statins, Ezetimibe, and PCSK9 Inhibitors to Lower LDL Cholesterol: How Low Can You Go?
Jorge Plutzky, MD |
|
11:05am to 11:15am | Discussion, Q&A |
11:15am to 12:00pm |
Heart Failure with Preserved Ejection Fraction
Nancy K. Sweitzer, MD, PhD |
|
12:00pm to 12:10pm | Discussion, Q&A | |
12:10pm to 1:10pm | Break for lunch* |
1:10pm to 1:40pm |
Ventricular Assist Devices and the Artificial Heart
Mandeep Mehra, MD |
|
1:40pm to 1:50pm | Discussion, Q&A | |
1:50pm to 2:20pm |
Cardiac Transplantation: Current and Future Perspectives
Michael M. Givertz, MD |
|
2:20pm to 2:30pm | Discussion, Q&A | |
2:30pm to 3:00pm |
Heart Failure with Reduced Ejection Fraction
Akshay S. Desai, MD, MPH |
|
3:00pm to 3:10pm | Discussion, Q&A | |
3:10pm to 3:40pm |
Health-Related Quality of Life Outcomes in Heart Failure
Eldrin F. Lewis, MD, MPH |
|
3:40pm to 3:50pm | Discussion, Q&A | |
3:50pm to 4:10pm |
Snack break
Refreshments provided |
|
4:10pm to 4:40pm |
Cardiac Amyloidosis: New Treatments, New Hope
Rodney H. Falk, MD |
|
4:40pm to 4:50pm | Discussion, Q&A | |
4:50pm to 5:20pm |
The Burgeoning Field of Cardio-Oncology
Anju Nohria, MD |
|
5:20pm to 5:30pm | Discussion, Q&A | |
5:30pm to 6:00pm |
Heart Failure in Adult Congenital Heart Disease: An Echocardiographic Montage
Keri Shafer, MD |
|
6:00pm to 6:10pm | Discussion, Q&A |
6:30am to 7:45am | Breakfast | |
7:45am to 8:00am | Seating |
8:00am to 8:30am |
Epidemiology of Atrial Fibrillation: New Emphasis on Modification of Cardiovascular Risk Factors and New Concept of Atrial Fibrillation as a Systemic Cardiovascular Illness
Usha Tedrow, MD |
|
8:30am to 8:40am | Discussion, Q&A | |
8:40am to 9:10am |
Atrial Fibrillation: Pharmacological Therapy and New Approaches to Ablation in the EP Lab
Paul Zei, MD, PhD |
|
9:10am to 9:20am | Discussion, Q&A | |
9:20am to 9:50am |
Management of Atrial Fibrillation by the General Cardiologist: Lessons from Randomized and Observational Clinical Trials
David T. Martin, MD |
|
9:50am to 10:00am | Discussion, Q&A | |
10:00am to 10:20am |
Coffee break
Refreshments provided |
|
10:20am to 10:50am |
Is There a Role for Electronic Decision Support in the Management of Atrial Fibrillation and Other Cardiovascular Illnesses?
Samuel Z. Goldhaber, MD |
|
10:50am to 11:00am | Discussion, Q&A | |
11:00am to 11:30am |
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Pathogenesis and Management
Neal K. Lakdawala, MD, MSc |
|
11:30am to 11:40am | Discussion, Q&A |
11:40am to 12:25pm |
Atrial Fibrillation and Coronary Artery Disease: A Perilous Combination
Deepak L. Bhatt, MD, MPH |
|
12:25pm to 12:35pm | Discussion, Q&A | |
12:35pm to 1:35pm | Break for lunch* |
1:35pm to 2:05pm |
Tricuspid Valve Disease
Dale S. Adler, MD |
|
2:05pm to 2:15pm | Discussion, Q&A | |
2:15pm to 2:45pm |
Mitral Valve Disease
Patrick T. O'Gara, MD |
|
2:45pm to 2:55pm | Discussion, Q&A | |
2:55pm to 3:25pm |
Aortic Valve Disease
Yee-Ping Sun, MD |
|
3:25pm to 3:35pm | Discussion, Q&A | |
3:35pm to 3:55pm |
Snack break
Refreshments provided |
|
3:55pm to 4:25pm |
Transcatheter Aortic Valve, Mitral Valve, and Tricuspid Valve Therapies
Pinak B. Shah, MD |
|
4:25pm to 4:35pm | Discussion, Q&A |
4:35pm to 5:05pm |
Idiopathic Pulmonary Hypertension: Definition, Diagnosis, and Epidemiology
Bradley A. Maron, MD |
|
5:05pm to 5:15pm | Discussion, Q&A | |
5:15pm to 5:45pm |
Idiopathic Pulmonary Hypertension: Combination Pharmacological Therapy—Rationale and Results
Aaron B. Waxman, MD, PhD |
|
5:45pm to 5:55pm | Discussion, Q&A | |
5:55pm to 6:25pm |
Chronic Thromboembolic Pulmonary Hypertension
William Auger, MD |
|
6:25pm to 6:35pm | Discussion, Q&A |
6:30am to 7:45am | Breakfast | |
7:45am to 8:00am | Seating |
8:00am to 8:30am |
Management of Acute Coronary Syndromes
Marc S. Sabatine, MD, MPH |
|
8:30am to 8:40am | Discussion, Q&A | |
8:40am to 9:10am |
New Approaches to STEMI in the Cardiac Cath Lab: Should Our Goal Be Complete Revascularization? What Are Our Options for Intravenous Antiplatelet Therapy?
Brian A. Bergmark, MD |
|
9:10am to 9:20am | Discussion, Q&A | |
9:20am to 9:50am |
Long-Term Antiplatelet Therapy for Coronary Artery Disease: Single, Dual, or Even Triple Therapy? How Intense? Optimal Duration? Should Aspirin Be the First Antiplatelet Agent That We Discontinue?
Michelle L. O'Donoghue, MD, MPH |
|
9:50am to 10:00am | Discussion, Q&A | |
10:00am to 10:20am |
Coffee break
Refreshments provided |
|
10:20am to 10:50am |
Total Coronary Occlusion: The Last Fronier and Greatest Challenge for the Interventionalist in the Cath Lab
Kevin J. Croce, MD, PhD |
|
10:50am to 11:00am | Discussion, Q&A | |
11:00am to 11:30am |
The Aspirin Perplex: Whom to Treat and What Dose to Use?
Samia Mora, MD |
|
11:30am to 11:40am | Discussion, Q&A |
11:40am to 12:25pm |
Sudden Cardiac Death: Identifying Patients at High Risk, Optimizing Preventive Measures, and Managing Patients Who Are Successfully Resuscitated
Gordon F. Tomaselli, MD |
|
12:25pm to 12:35pm | Discussion, Q&A | |
12:35pm to 1:35pm | Break for lunch* |
1:35pm to 2:05pm |
DOACs: The Good, the Bad, and the Ugly
Samuel Z. Goldhaber, MD |
|
2:05pm to 2:15pm | Discussion, Q&A | |
2:15pm to 2:45pm |
Management of Major Bleeding Complications in Anticoagulation Patients
Jean M. Connors, MD |
|
2:45pm to 2:55pm | Discussion, Q&A | |
2:55pm to 3:10pm | Transition to Breakout Sessions |
3:10pm to 4:00pm |
Breakout Sessions I, II, III
Session I: Difficult Dilemmas That My Patients and I Have Confronted |
|
4:00pm to 4:10pm | Transition | |
4:10pm to 5:00pm |
Breakout Sessions I, II, III
Session I: Difficult Dilemmas That My Patients and I Have Confronted |
|
5:00pm to 5:10pm | Transition | |
5:10pm to 6:00pm |
Breakout Sessions I, II, III
Session I: Difficult Dilemmas That My Patients and I Have Confronted |
6:30am to 7:45am | Breakfast | |
7:45am to 8:00am | Seating |
7:30am to 7:50am |
Lymphedema and Limb Swelling: Assessment and Cutting Management
Brett Carroll, MD |
|
7:50am to 8:00am | Discussion, Q&A | |
8:00am to 8:30am |
Cold and Blue Fingers and Toes: Work-Up and Management
Marie D. Gerhard-Herman, MD |
|
8:30am to 8:40am | Discussion, Q&A | |
8:40am to 9:10am |
Pulmonary Embolism Response Teams: Optics and Options—Rolling Out a Coordinated Communications Strategy
Samuel Z. Goldhaber, MD |
|
9:10am to 9:20am | Discussion, Q&A | |
9:20am to 9:50am |
Pulmonary Embolism and DVT: Epidemiology, Pathophysiology, Misconceptions, and Management Overview
Samuel Z. Goldhaber, MD |
|
9:50am to 10:00am | Discussion, Q&A | |
10:00am to 10:20am |
Coffee break
Refreshments provided |
|
10:20am to 10:50am |
Peripheral Arterial Disease: Lessons from the COMPASS Trial and Implementation of Combination Anticoagulation and Antiplatelet Therapy
Umberto Campia, MD, MS |
|
10:50am to 11:00am | Discussion, Q&A | |
11:00am to 11:30am |
Quiz: Vascular Diagnostic Lab Cases
Piotr Sobieszczyk, MD |
|
11:30am to 11:40am | Discussion, Q&A |
11:40am to 12:25pm |
Case Discussion: From Bedside to Bench
Joseph Loscalzo, MD, PhD |
|
12:25pm to 12:35pm | Discussion, Q&A | |
12:35pm to 1:35pm | Break for lunch* |
1:35pm to 2:05pm |
Ventricular Tachycardia "Storm" and Other EP Emergencies: A Case-Based Approach to Management, including Ventricular Tachycardia Ablation
Usha Tedrow, MD |
|
2:05pm to 2:15pm | Discussion, Q&A | |
2:15pm to 2:45pm |
Rapid-Fire Case-Based Arrhythmia Quiz
Bruce Koplan, MD |
|
2:45pm to 2:55pm | Discussion, Q&A |
2:55pm to 3:25pm |
How to Select, Use, and Integrate the Results of Cardiovascular Imaging Tests: CT, Magnetic Resonance, and Nuclear Imaging
Ron Blankstein, MD |
|
3:25pm to 3:35pm | Discussion, Q&A | |
3:35pm to 3:55pm |
Coffee break
Refreshments provided |
|
3:55pm to 4:25pm |
Challenges and Advances in Transthoracic and Transesophageal Echocardiography
Justina C. Wu, MD, PhD |
|
4:25pm to 4:35pm | Discussion, Q&A | |
4:35pm to 5:05pm |
How to Choose the Best Stress Test: Exercise Treadmill, Exercise Bicycle, Exercise ECHO, Nuclear, or Magnetic Resonance
Marcelo F. DiCarli, MD |
|
5:05pm to 5:15pm | Discussion, Q&A | |
5:15pm to 5:45pm |
Cardiac Magnetic Resonance Imaging: Sarcoid, Amyloid, Pericardial Inflammation, Hemochromatosis, and Other Cardiac Infiltrative Diseases
Raymond Y. Kwong, MD, MPH |
|
5:45pm to 5:55pm | Discussion, Q&A | |
5:55pm to 6:25pm |
Cardiopulmonary Exercise Testing: Indications, Noninvasive, and Invasive
Bradley A. Maron, MD |
|
6:25pm to 6:35pm | Discussion, Q&A |
6:30am to 7:45am | Breakfast | |
7:45am to 8:00am | Seating |
8:00am to 8:30am |
The Emerging Field of Critical Care Cardiology: Managing Multisystem Organ Failure in Patients with Underlying Catastrophic Cardiac Insult
Erin Bohula, MD, DPhil |
|
8:30am to 8:40am | Discussion, Q&A |
8:40am to 9:10am |
Primer on Essential Genetics for the Practicing Clinician: A Case-Based Approach
Rajat M. Gupta, MD |
|
9:10am to 9:20am | Discussion, Q&A | |
9:20am to 9:50am |
Implications of a Genetics Workup in Hypertrophic Cardiomyopathy: How Genetic Profiling Can Inform the Decision to Implant or Withhold an Internal Cardiac Defibrillator
Carolyn Y. Ho, MD |
|
9:50am to 10:00am | Discussion, Q&A | |
10:00am to 10:20am |
Coffee break
Refreshments provided |
|
10:20am to 10:50am |
Arrhythmogenic Cardiomyopathy: When and Why Refer to a Cardiovascular Geneticist?
Neal K. Lakdawala, MD, MSc |
|
10:50am to 11:00am | Discussion, Q&A | |
11:00am to 11:30am |
Randomized and Observational Trials of Heart Failure: Lessons I Have Learned as a Clinician
Scott D. Solomon, MD |
|
11:30am to 11:40am | Discussion, Q&A |
11:40am to 12:25pm |
Heart Disease: Past, Present, and Future
Eugene Braunwald, MD |
|
12:25pm to 12:35pm | Discussion, Q&A | |
12:35pm to 1:35pm | Break for lunch* |
1:35pm to 2:05pm |
Exponential Advances in Our Understanding of Pharmacological Therapy to Reduce Heart Attack, Stroke, and Cardiovascular Death in Patients with Diabetes: Gleaning Information from a Series of Remarkable Randomized Control Trials
Marc A. Pfeffer, MD, PhD |
|
2:05pm to 2:15pm | Discussion, Q&A | |
2:15pm to 2:45pm |
A New Day Dawns in Management of CV Risk in Diabetes Mellitus: Attacking from All the Angles
Benjamin M. Scirica, MD |
|
2:45pm to 2:55pm | Discussion, Q&A | |
2:55pm to 3:25pm |
Playing Against a Stacked Deck: Managing Cardiovascular Risk in Chronic Kidney Disease
Ajay Singh, MD |
|
3:25pm to 3:35pm | Discussion, Q&A | |
3:35pm to 4:05pm |
Diabetes Mellitus for the Clinical Cardiologist: A Step-Wise Approach to Management—Do We Have to Start with Metformin? Should We Prescribe Routinely the Newest Agents That Reduce Cardiovascular Outcomes with Only Modest Reduction of Hemoglobin A1C?
Enrico Cagliero, MD |
|
4:05pm to 4:15pm | Discussion, Q&A |
4:15pm to 4:45pm |
Cardiovascular Management of Complicated Pregnancy
Anne Marie Valente, MD |
|
4:45pm to 4:55pm | Discussion, Q&A | |
4:55pm to 5:00pm |
Concluding Remarks and Wrap-Up
Samuel Z. Goldhaber, MD |
|
5:00pm | Course Adjourns |
*There are many convenient and varied lunch options within a short walking distance of the course.